Literature DB >> 29884474

Potentials of CRISPR in liver research and therapy.

Robin Loesch1, Christèle Desbois-Mouthon2, Sabine Colnot3.   

Abstract

The CRISPR technology is rapidly transforming the field of liver research by its versatility and easy use. In vivo gene editing of hepatocytes in adult mice can be achieved using a broad toolbox for both fundamental research and development of therapeutic strategies for future clinical applications. Recent studies showed that CRISPR has a real potential to treat hereditary liver diseases as well as virally induced pathologies. This short review recapitulates very recent advancements regarding the use of CRISPR in liver research and therapy.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CRISPR; In vivo; Liver; Research; Therapy

Mesh:

Year:  2018        PMID: 29884474     DOI: 10.1016/j.clinre.2018.05.001

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  2 in total

Review 1.  Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.

Authors:  Huimin Kong; Enguo Ju; Ke Yi; Weiguo Xu; Yeh-Hsing Lao; Du Cheng; Qi Zhang; Yu Tao; Mingqiang Li; Jianxun Ding
Journal:  Adv Sci (Weinh)       Date:  2021-10-19       Impact factor: 16.806

2.  Exploring the most stable aptamer/target molecule complex by the stochastic tunnelling-basin hopping-discrete molecular dynamics method.

Authors:  Chia-Hao Su; Hui-Lung Chen; Shin-Pon Ju; Tai-Ding You; Yu-Sheng Lin; Ta-Feng Tseng
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.